-
FoI Number
-
2023-370
-
Subject
-
Asthma Medication
-
Date Received
-
22/09/2023
-
Request and Response
-
- How many patients have been treated (for any condition) in the last 4 months with:
| Benralizumab |
0 |
| Dupilumab |
4 |
| Omalizumab |
4 |
| Reslizumab |
0 |
| Mepolizumab |
2 |
| Tezepelumab |
0 |
- Of the patients treated in the last 4 months with any of the above products, please provide the number of patients by the following age groups:
| Age 6 – 11 |
0 |
| Age 12 – 17 |
1 |
| Age 18 and above |
9 |
- How many patients have been treated in the last 4 months by the Respiratory Medicines Department ONLY with?:
